Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0YNOYQ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
HLX-42
|
|||||
| Synonyms |
HLX 42; HLX-42; HLX42; YL221
Click to Show/Hide
|
|||||
| Organization |
Shanghai Henlius Biotech, Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
8
|
|||||
| Antibody Name |
A highly specific humanized IgG1 anti-EGFR
|
Antibody Info | ||||
| Antigen Name |
Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
DNA topoisomerase-I inhibitor
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
